IONIS PHARMACEUT. DL-001 earnings per share and revenue

ISI earnings per share for the last quarter are -0.91 EUR whereas the estimation was -0.96 EUR which accounts for 5.12% surprise. Företagets omsättning för samma period uppgår till 110.29 M EUR trots den uppskattade siffran 121.80 M EUR. Estimated earnings per share for the next quarter are -0.90 EUR, and revenue is expected to reach 136.14 M EUR. Also watch annual changes over time to get a bigger picture of ISI earnings per share and revenue dynamics.